Showing results (1431-1440 of 1,906) with videos related to

Sort By:
Pageof 191
Brain : a Journal of Neurology|April 1, 1996
Early spontaneous hyperperfusion after stroke. A marker of favourable tissue outcome?G Marchal, M Furlan, V Beaudouin, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 13, 2025
Door-In-Door-Out Times and Functional Outcomes after Stroke in a Large Canadian Hub-and-Spoke NetworkAymen Sahal, Joel Neves Briard, Leila Azzi, et al.
Human Pathology|June 29, 2013
Histologic prognostic factors associated with chromosomal imbalances in a contemporary series of 89 clear cell renal cell carcinomasJulien Dagher, Frederic Dugay, Gregory Verhoest, et al.
BJU International|June 9, 2021
Cancer-associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti-angiogenic therapyDamien Ambrosetti, Michael Coutts, Charlotte Paoli, et al.
Nature Immunology|March 4, 2026
HLA class I signal peptide variation predicts strength of NKG2A+ NK cell response to missing-self and risk of human diseaseZhansong Lin, Arman A Bashirova, Cian Callahan, et al.
Faraday Discussions|May 1, 2026
The ever-evolving active site: transformation of single atoms to extended structures during the Rh-catalyzed reverse water-gas shift reactionGreg Barber, Xiaobo Chen, Anastassiya Khan, et al.
Cancer Immunology, Immunotherapy : CII|July 25, 2003
Cytotoxic effector cells with antitumor activity can be amplified ex vivo from biopsies or blood of patients with renal cell carcinoma for cell therapy useFrançoise Bouet-Toussaint, Jean-Jacques Patard, Alban Gervais, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 13, 2010
[Prognostic value of erythrocyte polyamines levels in renal cell carcinoma. Prospective study in 418 cases]P Bigot, G Lughezzani, K Bensalah, et al.
Advances in Health Sciences Education : Theory and Practice|May 8, 2020
Accuracy of rating scale interval values used in multiple mini-interviews: a mixed methods studyPhilippe Bégin, Robert Gagnon, Jean-Michel Leduc, et al.
International Journal of Molecular Sciences|April 9, 2020
Immunotherapy in Renal Cell Carcinoma: The Future Is NowAntoine Deleuze, Judikaël Saout, Frédéric Dugay, et al.
Pageof 191